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Role of Forensic Chemistry and Analytical Instrumentation in the Identification of
Designer Drugs
Mariah Barko
Dr. Karim Abdelhay
This thesis describes the overall issues that designer drugs are causing in society
today. There are three main types of structural differences between designer drugs and
the parent drug they are created from. The substances can be direct or indirect
regioisomers with the same atomic components as the parent drug or isobaric compounds
containing different atomic components than the parent drug. These substances are
slowly becoming classified as stimulants, sedatives, dissociative, psychedelics, or
synthetic cannabinoids, and scheduled into one of the classes set in place by the
Controlled Substances Act of 1970, appropriately once enough information is known
about them. Many different instrumentation techniques can be used to help identify these
designer drugs and assist with the process of relating them to a specific designer drug
family. Some of the most important forensic instruments for this identification process
include Gas Chromatography, Mass Spectrometry, and Fourier Transform Infrared
Spectroscopy. Overall, these designer drugs need to be analyzed and researched more in
order to put proper polices into place to ultimately save the lives of many.
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Over the years within the Forensic Chemistry field there have been major
advancement with the technology and instrumentation used to analyze evidence and
different compounds. Some of the major compounds that forensic drug chemists analyze
in the laboratory include designer drugs, which are normally derivatives, or analogs, of
pre-existing drugs where their chemical structure becomes altered by chemical processes.
Designer drugs can also have a different structure than any pre-existing drug but produce
the same mind-altering effects as a pre-existing drug. The chemical processes make it so
that natural drug substances that come from plants and animals are less popular because
these synthetic drug substances, that are created within a laboratory, have stronger, more
potent, effects on the human body (1). Many synthetically made drugs have a lot of
changes made to their structure or structural orientation of substituents in order to create
these derivatives which can make it very difficult for the forensic chemists working in the
laboratories to identify these newly formed drugs quickly. Without knowing the drug’s
chemical structure, it can be difficult to know to effects it will cause to the human body.
These new designer drugs are being created in order to bypass existing drug laws, like the
Controlled Substance Act of 1970 that created a system where drugs were placed into one
of five different scheduled levels (2). Schedule I drugs have a very high potential for
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abuse and are not acceptable to be prescribed for medical use. Schedule II drugs have a
slightly lower potential for abuse and are very rarely prescribed for medical purposes.
Schedule III drugs have an intermediate potential for abuse and are more commonly used
for medical purposes. Schedule IV drugs have a very low potential for abuse and are
prescribed very often for medical uses. Schedule V drugs have the lowest potential for
abuse and are most commonly prescribed for medical purposes (2). By creating drugs
with no restrictions on them, these drugs become a legal way for people to get high (1).
Designer drugs are created in clandestine laboratories, which can be defined by the US
Department of Justice (3) as, “An [illegal] operation consisting of a sufficient
combination of [equipment] and chemicals that either has been or could be used in the
synthesis of [illicit] substances.” The illicit substances mentioned are what can be
classified as designer dugs.
The types of derivatives that are being created of these drugs include direct
regioisomers, indirect regioisomers, and isobaric compounds. Direct regioisomers differ
from the original compound by having a different arrangement of the substituents
connected to the main structure, but they have the same exact mass as the original
compound. Indirect regioisomers differ from the original structure by having a different
structural arrangement of the molecules, and they also will have the same exact mass of
the original compound. Unlike direct and indirect regioisomers, isobaric compounds have
a different atomic composition from the original drug, which results in a differing exact
mass from the original compound. Examples of these different derivatives can be seen in
Figure 1. The top two compounds in this figure can be identified as direct regioisomers
because the methyl group moved from being in an ortho-arrangement meta-arrangement
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on the aromatic ring. The middle two compounds can be identified as indirect
regioisomers because the methyl group in this structure goes from being attached to the
Oxygen of one substituent to being connected directly to the aromatic ring. The bottom
two compounds shown in this figure can be identified as being isobaric compounds
because the atomic composition is different between the two structures. The original drug
shown on the right has one methyl group substituent and one methoxy group so overall
this compound only contains one Oxygen atom. The isobaric compound differs
atomically from the original compound because instead of the two substituents
mentioned, this compound contains a methylenedioxy group so overall this compound
contains two Oxygen atoms.
Although there is an increasing amount of designer drugs being created by altering
other substance’s chemical structure, it is also important to realize that not all of the
possible derivatives within one drug family are possible drugs of abuse. Some of the
derivatives of these substances are inactive derivatives, substances that will not be used
for abusive purposes because they lack the structural properties that would cause them to
be abusable. Every drug family contains some substances with a specific chemical
structure that causes them to be these inactive derivatives. It is very important for
forensic chemists to know the differences between abusable derivatives within a drug
family and the inactive derivatives that may be used for other chemical purposes. A
proper process needs to be put into place to differentiate between the different types of
substances so that no chemists run into trouble when using the inactive derivatives of
these substances for purposes within the lab just because they could be mistaken for an
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active abusable substance. The different types of forensic instrumentation can be used to
identify the structure of questioned samples to help with this differentiation process.

Figure 1: Examples of direct regioisomers, indirect regioisomers, and isobaric
compounds (4).

It is very important to recognize that the amount of newly created designer drugs is
increasing rapidly at a rate that makes it very difficult for police officers, forensic
chemists, medical professional, and the public to keep up with all the new information
that is being done to identify and classify these compounds. Many different groups of
scientists are working on the identification and classification processes for these drugs so
staying up to date on the new research and working well together is very crucial for all
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the workers mentioned (5). The different types of designer drugs will produce different
types of effects on the human body depending on how they interact with the brain and the
body. Many new substances that have similar effects as already existing drugs of abuse
will also follow to same biochemical interactions with the human body (6). The constant
repeat of abuse of these substances will cause a person to develop a dependance on the
euphoric effects.
One classification of these drugs is a stimulant substance, which is normally one of the
most widely used type of substance. Stimulants will boost the happiness within a person
by interacting with the monoamine transporters in the body and effecting the levels of
norepinephrine, dopamine, and serotonin, by increasing them significantly (6). Many
normal body functions and a person’s mood will be altered if this type of drug is abused.
Quite a lot of the different drug families are classified as stimulant substances.
Another classification of designer drug is a sedative substance, medically these are
prescribed as pain medication. Sedative substances will relieve people by calming them
down, reducing anxiety and creating a euphoric feeling. These substances will bind to the
opioid receptors in the brain to cause the effects mentioned (6). There are not as many
sedative type substances as there are stimulant substances.
Synthetic cannabinoids have their own classification type when discussing designer
drugs. These drugs are very similar to sedative substances because they produce the same
effects, however these with interact with the CB1 and CB2 receptors in the body (6). This
is the largest classification type of designer drugs, containing the most compounds with
differing structural components.
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One other classification of these substances are ones that create psychedelic effects,
and sometimes these were used by religious groups or for people to relax. These
substances interact with the 5-HT2A and 5-HT2C receptors to produce their effects in the
human body (6). This is a smaller classification type since there is not a large number of
psychedelic drugs.
One last classification of designer drugs is the dissociative substances; these
substances have very distinctive effects on the human body. An individual will not feel
any pain when under the influence of this drug, and these can also be used as a fast-acting
anti-depressant substitute. Dissociative substances will interact with the ionotropic
glutamatergic NMDA receptors in the body (6). It is very helpful to know which
classification each new drug belongs to, but normally the structural components of the
sample in question must be identified first, which is completed by using proper analytical
instrumentation within the forensic chemistry labs.
There are many different instruments found within a forensic chemistry laboratory that
aid in the process of identifying these designer drugs. As the instrumentation used to
identify these drugs has improved of the years, the scientists have been able to identify
some types of these designer drugs more quickly. It can still be quite difficult to identify
the isobaric drug compounds because they do not have a chemical structure that is similar
to any pre-existing drugs. Some of the most important forensic instruments that are used
to successfully identify designer drugs include Gas Chromatography (GC), Mass
Spectrometry (MS), Fourier-Transform Infrared Spectroscopy (FTIR), Liquid
Chromatography (LC), Direct Analysis in Real Time (DART), and Nuclear Magnetic
Resonance (NMR). These instruments can be used by themselves for an identification
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process, or some instruments can be paired together in order to get as much information
as possible about the drugs throughout the identification process. Each of the formerly
mentioned instruments are used to identify different aspects of compounds, and it is
important when forensic chemists do not have any information on a brand-new designer
drug that they use all the instrumentation they have at their disposal to gain as much
information as quickly as possible. Using these different processes will also help a
chemist come to a widely accepted conclusion. If multiple instruments or other analytical
tests are used to identify the drug in question. The guidelines that need to be followed to
make a clear decision on a drugs identity can be found within the Scientific Working
Group for the Analysis of Seized Drugs (SWGDRUG). Each of the different instruments
and tests are separated into three categories A, B, and C, and only the use of multiple
uncorrelated processes will positively confirm the determined identity of the drug in
question. If a category A process is used during analysis, then only one other process
from any of the categories is required to confirm the results, but if a category A test is not
used during the analysis, then three instruments or techniques must be used to confirm
the results (7). Ultimately, advancements in forensic instrumentation and technology are
improving the speed at which new designer drugs are being identified and scheduled,
which will lead to better polices and enforcements, as well as saving lives.
A Gas Chromatography instrument is a category B analytical technique. This process
will take a liquid sample, usually created from dissolving the solid compound within a
solvent and heat it while it goes through the instrument for the analysis. The sample will
become separated into all its molecular components which will be displayed on a
chromatogram showing a peak for each compound along with the time it took for it to
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elute from the instrument. An example chromatogram can be seen in Figure 2. In this
chromatogram each peak is representative of a designer drug from the Cathinone family
each with a different arrangement of one substituent group between the a and b
compounds, and a one carbon difference, added to the side chain, between compounds 1,
2, and 3. This figure shows how this instrument can distinguish between regioisomeric
compounds as well as isobaric compounds because each compound within the mixture
will elute from the sample at a different time, even when the changes are miniscule. This
instrument is largely used for samples that have a mixture of compounds within them
because it will separate them and give the identity of all of the compounds within the
sample. Two forensic instruments that can be used alongside the Gas Chromatographer
are a Mass Spectrometer and a Fourier-Transform Infrared Spectrometer.

Figure 2: A Gas Chromatogram showing the different elution times between
regioisomers, structures a and b, and isobaric compounds, structures 1, 2, and 3 (10).
A Mass Spectrometry instrument is a category A analytical technique. This process
will take a sample and break it down into the main structural groups located within the
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compound. This process occurs by having the sample travel through a section of the
instrument that will electrically charge the compound to create fragmented ions, charged
particles. These fragmented ions will then travel through the mass analyzer part of the
instrument where they will be separated based on their charge to mass ratio, or their m/z
value. The output data for this type of instrument is called a mass spectrum and it will
show peaks at specific m/z values for fragmentations of the original compound and the
peak height is based on how abundant that fragment is for that compound. An example
mass spectrum can be seen in Figure 3. This mass spectrum is representative of the
compound 2-Ethylenecathinone, also a part of the cathinone family like the compounds
discussed on the gas chromatogram. The peaks on this spectrum represent the ways in
which this structure can fragment to create ions. The more abundant the peak, the more
likely that type of fragmentation will occur much like the peak at the 72 m/z value; the
arrows on the structure show where this compound will break apart to create this ion. The
process of mass spectrometry is one of the most used during the identification of designer
drugs because it will give the fragmentation patterns of the compound based on its
structure, as well as the exact mass of the compound in question. Mass spectrometers are
very equipped to be used alongside many other forensic instruments and other analysis
processes such as mass defect filtering (8). Mass Defect Filtering is a process that is
completed after a sample has been ran on the Mass Spectrometer where the structural
similarities and differences between the drug in question and other types of known
substances are compared using a library system. Figure 4 shows an example of how
Mass Defect Filtering can be used to match compounds in question to the drug family
they belong to, in this case completely synthetic cannabinoids. In this figure the diagram
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shows a popular abusable designer drug JWH-018 and compounds with identical
structures to this drug except the addition or subtraction of on methyl group, CH3 group,
within the alkyl side chain. Because the difference between these derivatives and the
original drug is the addition or subtraction of such a small component, then the mass does
not change that significantly and ultimately the structures of these two derivatives is
almost unnotably different. Using this process has shown to be a very effective method
because it compares the sample and the library results by their structural components and
their exact atomic mass. This process can be used to identify which of the main drug
families the sample would most likely belongs to, or it can at least give a more reasonable
starting place to where it may belong if it is an isobaric compound based on the central
structural components.

Figure 3: Mass spectrum of a drug within the cathinone family with its most abundant
fragments (9).
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Figure 4: Diagram of the Mass Defect Filtering process of cannabinoid compounds (8).
Fourier-Transform Infrared Spectroscopy is a category A analytical technique. This
instrument will send infrared light waves towards a sample, some of which will be
absorbed by the sample, but the infrared waves that pass through the sample are the ones
detected by the instrument. The output data for this process is an Infrared spectrum which
will show a unique fingerprint for every sample. An example Infrared spectrum can be
seen in Figure 5. This spectrum shows another drug compound within the cathinone
family. Each peak represented on this spectrum is specific for each molecular group
within this compound. The peaks within the 400-1500 cm-1 wavelength range can help
differentiate between regioisomers because they are very specific for only that
compound’s arrangement of atoms. This information can give some insight into the
possible chemical structure of the compound. The Infrared spectrum of the compound in
question can also be compared against library match results of compounds with similar
structures and a percentage of how likely the two spectra match will be given as well.
Finding out the possible structural matches to the compound in question can be crucial

12
information when dealing with identifying designer drugs and when looking at multiple
drugs within the same family with slight structural changes.

Figure 5: An Infrared spectrum of a cathinone substance (10).
Liquid Chromatography is a category B analytical technique. This instrument is a
separation technique much like the Gas Chromatography technique, however Liquid
Chromatography is not as sensitive of a technique as Gas Chromatography (11). This
process can be beneficial for any compounds that have heat sensitivity. This process uses
a liquid sample and by using a large amount of pressure and other solvents, the
compound is able to be separated into its molecular components. One type of Liquid
Chromatography is High Performance Liquid Chromatography which is a very precise
and sensitive process. Liquid Chromatography is also largely used to separate mixtures
into their individual molecular components. The output data from this instrument will
also be shown on a chromatogram where each peak will represent a compound from
within the sample as well as information about its elution time from the instrument. A
chromatogram from this instrument would look very similar to a chromatogram from a
Gas Chromatographer. The Liquid chromatographer can be connected to a mass
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spectrometer to allow for the analysis process to provide data from both instruments and
can be used for the same analysis process as a Gas Chromatographer-Mass Spectrometer.
Direct Analysis in Real Time is an ambient instrument that is usually paired with a
Time-of-Flight Mass Spectrometer (9). This type of instrument can be used directly in the
field when an unknown substance is collected from a scene. This process can be used in
place of Gas Chromatography-Mass Spectrometry or Liquid Chromatography-Mass
Spectroscopy (12). This instrument pairs well with a Mass Spectrometer because it is
also a technique where the atoms of the sample become charged particles, ions, to be
analyzed. The output data from this instrument will be shown on a spectrum similarly as
well and each peak will represent a fragment of the structure in question. This instrument
was used to analyze a mixture of drugs and all the results were accurate when the
compounds need to be differentiated form one another. These results were comparable to
results from a Gas Chromatogram-Mass Spectrometer but were more easily obtained with
absolutely no preparations made to the samples before they were ran through the
instrument (9).
Nuclear Magnetic Resonance Spectroscopy is a category A analytical technique. This
is used to determine the exact chemical structure of an unknown sample (13). This type
of spectroscopy will normally be used after the sample has already been ran on other
forensic instruments in the lab like Gas Chromatography-Mass Spectrometry. Similar to
the Mass Spectrometer, Nuclear Magnetic Resonance Spectroscopy will break the sample
down into fragmented sections, but this instrument will be able to determine the exact
chemical structure of the sample in question. A spectrum from this type of instrument can
be seen in Figure 6. This spectrum is representative of a synthetic cannabinoid

14
compound. On this spectrum every peak is labeled and corresponds to a specific part of
the structure showing just how accurate the process is in identifying the exact chemical
structure for samples. This process has been proven to work significantly well when
identifying the aromatic substituents as well as other aliphatic compounds (13).

Figure 6: A Nuclear Magnetic resonance spectrum of a fully synthetic cannabinoid
compound (13).
Out of all the forensic instruments mentioned so far, the Gas Chromatography-Mass
Spectrometry combination of instruments is used the most often when determining the
structure of the unknown substances when they are tested by the labs to see if they are
designer drugs. The process of using these instruments will allow the chemists to have a
better understanding of the number of compounds within the sample and the structure of
each compound found. Another way of looking at it, is that this process will tell the
chemists the DNA structure of the drug in question. The chromatogram obtained would
have a peak on it for every compound within the structure. Each peak would then have a
specific mass spectrum that correlates to it to give the overall structure of that particular
compound within the sample.
Because there is such a large demand for these types of substances, there is an
abundance of designer drugs that are on the streets today and the market for them keeps
growing and so many more are made every day. While these designer drugs are not just
normal drugs of abuse, they do normally originate from one type of drug of abuse and
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become synthetically altered to have a different structure or become a derivative of the
original structure. Because of this, designer drugs can be classified as being related to
many of the abusable drug families. Some of the main abusable drug families include
Cathinones, Cannabinoids, Amphetamines, Opioids, and of course there are many more.
Once chemists identify the chemical structure of the samples they are testing in the labs,
they can more easily classify which drug family they might belong to which can help
know what type of effects they will have on the human body.
The cathinone family contains some drugs that were widely used for medical purposes
until the addictive properties of these drugs were discovered then they were classified as
Schedule I stimulant compounds (2)(6). The abusable substances within the Cathinone
family are more widely known as bath salts. Cathinone drugs are normally created from
naturally occurring substances, but the bath salt derivatives have synthetically altered
chemical structures turning them into designer drugs. Another popular designer drug
within the cathinone family is MDPV, methylenedioxypyrovalerone, MDPV is a very
popular designer drug because it is easily purchased on the internet and will produce
similar effects to another widely abused drug ecstasy (14). There are three distinct
regions within the cathinone chemical structure where structural changes can be made to
make the possible derivatives. These three regions are on the aromatic ring, differing
lengths of the alkyl side chain, and within the amino group (10). The inactive derivatives
within this family have no alkyl side chain group within their structure (15). Figure 7
highlights the parts of this drugs structure where changes are made for each derivative.
The aromatic ring can be seen circled in blue, the alkyl side chain can be seen circled in
red and the amino group can be seen circled in black. The instruments that have been able
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to accurately identify these types of drug compounds include Gas Chromatography-Mass
Spectrometry, Liquid Chromatography-Mass Spectrometry, Fourier Transform Infrared
Spectroscopy, and Nuclear Magnetic Resonance Spectroscopy (10)(13)(14)(16).

Figure 7: A cathinone structure labeled at the places where changes are made
within the structure for derivative compounds.
The Cannabinoid family is very similar to the Cathinone family because it is also
normally a naturally occurring substance, cannabis, but can be modified structurally into
a designer drug. Cannabinoids will produce more potent effects on the human body than
normal cannabis would produce and, a large number of recently identified cannabinoid
derivatives have been classified as Schedule I drugs (8)(17). The derivatives within this
family can be broken down into three categories: psychoactive, active but not
psychoactive, and inactive, and interestingly there are more inactive derivatives than
active derivatives within this family (18). Psychoactive drugs will cause psychological
and behavioral effects and can be abusive. Substances that are active but not psychoactive
will cause some effects to the human body but are not abusive. Like mentioned
previously, inactive substances will have no abusable effect on the human body. The
most psychoactive derivative in the cannabinoid family is the delta 9tetrahydrocannabinol and structurally this compound only differs from an inactive
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derivative by one oxygen atom (18). Another very popular designer drug within this
family, that has recently been classified as a synthetic cannabinoid, scheduled, and made
illegal, is JWH-018, more widely known as spice (6)(17). This drug is a fully synthetic
compound and although this original compound is now scheduled and considered an
illegal substance, there have been a large number of compounds created by changing
small aspects to this drugs structure (8). These cannabinoid compounds will be
mislabeled and discretely sold as incense or a type of smokable herbs to not get
recognized by anyone in law enforcement (19). The main instruments that have been used
in the forensic chemistry labs to identify the structures of cannabinoid derivates include
Gas-Chromatography-Mass Spectrometry, Liquid Chromatography-Mass Spectrometry
with Mass Defect Filtering, Nuclear Magnetic Resonance, and Gas ChromatographyInfrared Analysis (8)(17)(14).
The amphetamine family of drugs are used as stimulants on the Central Nervous
System in the human body. The most popular designer drug derivative within this family
is methamphetamine. The only structural difference between amphetamine and
methamphetamine is the addition of one methyl group to the drugs structure, however the
processes to create each substance is slightly different from one another. Another
designer drug that is a part of the amphetamine family is p-fluoroamphetamine. The
designer drugs in this family have a decently high abuse potential, so they are labeled as a
Schedule II stimulant drug (2)(6). The instruments used to analyze these drugs structures
include Gas Chromatography-Mass Spectrometry and Nuclear Magnetic Resonance
Spectroscopy (13).
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The Opioid family has a large number of designer drugs within it all having a decently
high abuse potential and are considered Schedule II sedative drugs, however, these drugs
are regularly used for medical purposes, usually in hospitals (2)(6). A couple of the
designer drug derivatives within the Opioid family include acetylfentanyl, a derivative of
fentanyl, and Krokodil, a derivative of Codeine. The use of acetylfentanyl as an abuse
able drug became very popular in 2013, and since has grown in popularity amongst
people creating designer drugs. Acetylfentanyl is much more potent than normal fentanyl
so it is used in combination with other drugs like heroine to make it more cost efficient to
produce the designer drugs and they can still be sold at the same high price (2). The
chemical structure of the acetylfentanyl is very different than the more common opioids
like heroine or morphine so it can be hard to determine that it is a substance that is part of
the Opioid family. Acetylfentanyl can sometimes be detected by a process that is
screening for fentanyl, but these times of processes are not always used in the forensic
chemistry lab (2). Some of the previously mentioned instruments that can detect these
opioid derivatives within samples are Gas Chromatography-Mass Spectrometry and
Liquid Chromatography-Mass Spectrometry. Krokodil has become increasingly popular
across North America and European countries after it originated in Russia (20). This drug
was created for the sole purpose of being an inexpensive replacement for heroine. The
process, which can be seen in Figure 8, of making this drug consists of starting with
tablets of codeine that undergo synthetic changes within a clandestine lab with items that
can be easily bought, like gasoline and other chemicals, to create a deosmorphine salt
(21). The image of this process highlights the areas that change within the structure
between the normal opioid drug and its more potent derivative. Many presumptive tests
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can be done in the forensic labs to narrow down the possibility of if the substance in
question Krokodil, but the main two types of instruments used to analyze the compound
will be Gas Chromatography-Mass Spectrometry and Liquid Chromatography-Mass
Spectrometry (21). The deosmorphine salt has been detected and quantified by many
chemists using either one of these processes.

Figure 8: Chemical process of creating Krokodil, deosmorphine salt (21).
Like mentioned earlier, it is very important that forensic chemists are able to identify
the characteristics that will differentiate between active designer drugs, normally
derivatives of drugs of abuse, and substances that are inactive compounds which produce
zero abusive side effects. The most important information to determine about samples
like these types of derivatives is their analytical information. Out of all the techniques
discussed previously there are only really one instrumentation process that can properly
differentiate between active abusive compounds and inactive derivatives. This technique
is Gas Chromatography paired with an Infrared Detector; this detector follows the same
process as a Fourier Transform Infrared Spectrometer (11). This process can be
considered a confirmatory test when determining the identity of a designer drug since it
uses a category A and a category B technique. Even though Fourier Transform Infrared
Spectroscopy is within a category under SWGDRUG guidelines, this process goes more
in depth because it can separate all the compound within the sample before they are

20
examined by the Fourier Transform Infrared instrument (5). This technique can
differentiate between compounds like indirect and direct regioisomers better than a Gas
Chromatographer-Mass spectrometer instrument because of the uniqueness in the
fingerprint range on the spectra.
The reason why this process works better than using Fourier Transform Infrared
Spectroscopy by itself, is because normally the singular instrument cannot identify the
compounds well if there are multiple components within it because there is no separation
before the identification process, so more likely than not the only the compound that will
be identified is the most abundant one within the sample. The reason that the Gas
Chromatography-Fourier Transform Infrared Spectroscopy would work more efficiently
than Gas Chromatography-Mass Spectrometry is because the fingerprint range on the
Fourier Transform Infrared Spectra will be unique for each different arrangement of the
components in the sample (10). It will explain how the location of the substituents create
different peak patterns on the chromatogram. This is very different than the output data
from a mass spectrometer because the mass spectra will look the same for any drugs
within the same family that has the same atomic components in a similar chemical
structure, like regioisomers (11). Because they have this very similar composition, on the
spectra they will usually fragment within the same ways when they have the same
substituents, even in different locations. Mass Spectra showing two types of cathinone
substances can be seen in Figure 9, these two structures are direct regioisomers because
they have a differing arrangement of their methoxy group, the OCH3 group. Even though
these two structures have this different arrangement of their components, the fragment
peaks are located at the same m/z values with almost identical abundances for
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compounds. It would be very difficult to distinguish between these two compounds if
only a Mass Spectrometer was used to identify them. Infrared spectra showing the
differentiations between these same two samples with the Infrared Detector can be seen
in Figure 10. These are the same two structures as show in the previous photo, but on
this set of spectra there is differences spotted between the two compounds. The different
colored circles highlight an example of how two different clusters of three peaks will
look different between derivative structures. In the top spectrum the blue circled peaks
are not as defined from one another like they are in the bottom spectrum, but in the top
spectrum the red circled peaks are very separated from one another unlike the peaks
highlighted in the bottom spectrum. This process overall will give more accurate data that
can differentiate between these closely related derivatives like the direct and indirect
regioisomers between compounds within the same drug family then the Gas
Chromatography-Mass Spectrometry process because the Gas Chromatography Infrared
Detection process has the unique fingerprint marker for every small difference (10).
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Figure 9: Mass Spectra of two direct regioisomeric compounds (17).

23

Figure 10: Infrared spectra of two regioisomeric compounds (17).
Many of these new designer drugs are responsible for dozens of fatalities before they
can even be recognized as a problem and even more before they can be identified and
made illegal. And as always, as soon as one drug can be classified, another new
synthetically created drug pops up in its place flooding the streets for the process to begin
all over again (22). These designer drugs are being created either by altering the structure
of an already existing drug or by trying to recreate the effects of an already existing drug.
The main types of structures that can be created to make these different illicit substances
include direct regioisomers, indirect regioisomers, and isobaric compounds. Both types of
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regioisomers contain the same atomic components as the parent drug, but they are just
arranged in a different way. On the other hand, isobaric compounds do not contain the
same atomic components as the drug they are trying to mimic.
To speed up the process of identifying these new substances and their effects many
scientists are completing various types of research studies and forensic analysis tests
(8)(9)(10)(12)(13)(14)(16)(17)(19)(23)(24)(25)(26)(27)(28). These different studies are
focused on analyzing and identifying one drug substance or one drug family by
preforming many analytical tests with forensic instrumentation. Another type of study
that is very relevant to scientists, medical professionals, and police officers is one that
takes all known data for one specific drug or drug family and complies a very informative
review for those substances (15)(18)(29)(30). Because they the different structural
changes and the number of new substances is increasing rapidly, these types of articles
help keep everyone up to date as best as possible on the designer drug substances.
The different forensic instruments discussed earlier all have key components during
the analysis process that assist in the identification and classification of these illicit
substances. The Gas Chromatography and Liquid Chromatography instruments can
separate the multiple components of a sample from each other for better analysis. The
Mass Spectrometry instrument can determine the possible chemical structure of the
questioned sample to help determine which drug family it may belong in. The Direct
analysis in Real Time and Nuclear Magnetic Resonance instruments have very similar
output data to the Mass Spectrometry instrument. The Fourier Transform Infrared
Spectroscopy instrument and the Infrared detector are both able to produce the structural
information for a compound in question, however this instrument differs from Mass
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Spectrometry because it can tell the difference between active compounds and inactive
derivatives within the same drug family based on the unique fingerprint region on the
spectrum.
The two most important aspects to the identification process of these designer drugs
are: 1) making it possible for these drugs to become scheduled appropriately under the
Controlled Substance Act so that these substances can no longer be considered a legal
way to get high and 2) making sure the differences are known between the active
abusable compounds and their inactive derivatives so that no scientists receive
punishment for analyzing a non-abuseable compound in the laboratory. The most
effective forensic instrument to be used for this process is the Gas Chromatographer with
an Infrared detector.
Due to the major advancements in with the technology and instrumentation used in the
Forensic Chemistry laboratories the analysis process for evidence and different
questioned compounds are conducted much easier and more time efficient. Because these
designer drugs are being identified more quickly and more efficiently, then they can be
classified and scheduled within a faster time frame as well. All of this will lead to even
faster identification processes in the future as well as the placement of better policies
against these substances, which will ultimately save many lives globally.
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